A
Alberto La Rosa
Researcher at Asociación Civil Impacta Salud y Educación
Publications - 31
Citations - 2015
Alberto La Rosa is an academic researcher from Asociación Civil Impacta Salud y Educación. The author has contributed to research in topics: Population & Randomized controlled trial. The author has an hindex of 16, co-authored 31 publications receiving 1767 citations. Previous affiliations of Alberto La Rosa include University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Jacqueline Neuhaus,David R. Jacobs,Jason V. Baker,Jason V. Baker,Alexandra Calmy,Daniel Duprez,Alberto La Rosa,Lewis H. Kuller,Sarah Pett,Matti Ristola,Michael W. Ross,Michael G. Shlipak,Russell P. Tracy,James D. Neaton +13 more
TL;DR: Levels of high-sensitivity C-reactive protein, IL-6, D-dimer, and cystatin C are elevated in persons with HIV infection and remain so even after HIV RNA levels are suppressed with antiretroviral therapy.
Journal ArticleDOI
Adenovirus Infections in Adult Recipients of Blood and Marrow Transplants
Alberto La Rosa,Richard E. Champlin,Nadeem Q. Mirza,James Gajewski,Sergio Giralt,Kenneth V. I. Rolston,I. Raad,K. Jacobson,Dimitrios P. Kontoyiannis,Linda S. Elting,Estella Whimbey +10 more
TL;DR: Adenovirus infections are an important cause of morbidity and mortality in adult BMT recipients, particularly allogeneic transplant recipients with GVHD who are receiving immunosuppressive therapy, and the need for an effective, nontoxic antiviral therapy is apparent.
Journal ArticleDOI
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.
Jacqueline Neuhaus,Brian Angus,Justyna D. Kowalska,Alberto La Rosa,Jim Sampson,Deborah Wentworth,Amanda Mocroft +6 more
TL;DR: Among HIV-infected persons with higher CD4+ cell counts, SNA events occur more frequently and are associated with a greater risk of death than AIDS events, according to the Kaplan–Meier method.
Journal ArticleDOI
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
Timothy R. Sterling,Nigel A. Scott,José M. Miró,Guilherme Amaral Calvet,Alberto La Rosa,Rosa M Infante,Michael P. Chen,Debra Benator,Debra Benator,Fred M. Gordin,Fred M. Gordin,Constance A. Benson,Richard E. Chaisson,M. Elsa Villarino +13 more
TL;DR: Among HIV-infected persons with median CD4+ cell count of approximately 500 cells/&mgr;l, 3HP was as effective and safe for treatment of latent Mycobacterium tuberculosis infection as 9H, and better tolerated.
Journal ArticleDOI
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
Thomas B. Campbell,Laura M. Smeaton,N. Kumarasamy,Timothy P. Flanigan,Karin L. Klingman,Cynthia Firnhaber,Beatriz Grinsztejn,Mina C. Hosseinipour,Johnstone Kumwenda,Umesh G. Lalloo,Cynthia Riviere,Jorge Sanchez,Marineide Gonçalves de Melo,Khuanchai Supparatpinyo,Srikanth Tripathy,Ana Martinez,Apsara Nair,Ann Walawander,Laura Moran,Yun Chen,Wendy Snowden,James F. Rooney,Jonathan Uy,Robert T. Schooley,Victor De Gruttola,James Hakim,Edith Swann,Ronald L. Barnett,Barbara Brizz,Yvette Delph,Nikki Gettinger,Ronald T. Mitsuyasu,Susan H. Eshleman,Steven A. Safren,Susan A. Fiscus,Adriana Andrade,David W. Haas,Farida Amod,Vladimir Berthaud,Robert C. Bollinger,Yvonne J. Bryson,David D. Celentano,David Chilongozi,Myron S. Cohen,Ann C. Collier,Judith S. Currier,Susan Cu-Uvin,Joseph J. Eron,Charles Flexner,Joel E. Gallant,Roy M. Gulick,Scott M. Hammer,Irving F. Hoffman,Peter N. Kazembe,Newton Kumwenda,Javier R. Lama,Jody Lawrence,Chiedza Maponga,Francis Martinson,Kenneth H. Mayer,Karin Nielsen,Richard B. Pendame,Bharat Ramratnam,Ian Sanne,Patrice Severe,Thira Sirisanthana,Suniti Solomon,Steve Tabet,Taha E. Taha,Charles van der Horst,Christine Wanke,Joan Gormley,Cheryl Marcus,Beverly Putnam,Smanga Ntshele,Edde Loeliger,Keith A. Pappa,Nancy Webb,David Shugarts,Mark A. Winters,Renard S. Descallar,Joseph Steele,Michael Wulfsohn,Farideh Said,Yue Chen,John Martin,Norbert Bischofberger,Andrew K. Cheng,Howard Jaffe,Jabin Sharma,Selvamuthu Poongulali,Sandra W. Cardoso,Deise Lucia Faria,Sima Berendes,Kelly Burke,Rosie Mngqibisa,Cecilia Kanyama,Virginia Kayoyo,Wadzanai Samaneka,Anthony Chisada,Sharla Faesen,Suwat Chariyalertsak,Breno Santos,Rita Alves Lira,Anjali A. Joglekar,Alberto La Rosa,Rosa Infante,Mamta K. Jain,T. Petersen,Sheela Godbole,Sampada Dhayarkar,Judith Feinberg,Jenifer Baer,Richard B. Pollard,David M. Asmuth,Raman R. Gangakhedkar,Asmita Gaikwad,M. Graham Ray,Cathi Basler,Michael F. Para,Kathy J. Watson,Babafemi Taiwo,Donna V. McGregor,Henry H. Balfour,Beth D. Mullan,Ge Youl Kim,Michael K. Klebert,Gary M. Cox,Martha Silberman,Donna Mildvan,Manuel Revuelta,Karen T. Tashima,Helen Patterson,P. Jan Geiseler,Bartolo Santos,Eric S. Daar,Ruben Lopez,Laurie Frarey,David Currin,David H. Haas,Vicki L. Bailey,Pablo Tebas,Larisa Zifchak,Jolene Noel-Connor,Madeline Torres,Beverly E. Sha,Janice M. Fritsche,Michelle S. Cespedes,Janet Forcht,William A. O'Brien,Cheryl Mogridge,Christine Hurley,Roberto Corales,Maria Palmer,Mary Adams,Amneris E. Luque,Luis Lopez-Detres,Todd Stroberg +157 more
TL;DR: Findings of a randomized trial conducted in multiple countries regarding the efficacy of antiretroviral regimens with simplified dosing with positive results are reported.